American Industrial Hygiene Conference and Exposition, May 8-13, 2004, Atlanta, Georgia. Fairfax, VA: American Industrial Hygiene Association, 2004 May; :21
NIOSH developed the Immediately Dangerous to Life and Health (IDLH) values beginning in 1974. In 1994, NIOSH reviewed all IDLH values to insure they were adequately protective, adding 10% of the lower explosive limit as a new criterion. NIOSH currently recommends IDLHs for 398 of 620 substances for which it has recommended exposure limits. Although NIOSH introduced IDLHs as respirator selection criteria, their application has spread, including specific references in regulations and routine use by emergency responders. In 1998, NIOSH began reevaluating the IDLHs. Two NIOSH-funded studies reviewed 50 IDLHs. Based on available toxicity data, at least 14% were questionably protective and approximately 20% were over-protective. NIOSH has begun a process to revise IDLH documentations. This process includes developing standard protocols to assure IDLH documentations and resulting values are transparent. This presentation expands on results from the review studies and discusses progress to date, including draft protocols inferred below, for consistently applying various data. Issues surrounding concerns and roadblocks to protocol development are addressed, in part to elicit substantive responses to the following questions: Does low potential for significant airborne exposure make an IDLH value unnecessary? Is the exposure data hierarchy of inhalation > intraperitoneal > ingestion generally appropriate? Is the tenBerge, Cn * t, relationship best for time-scaling acute inhalation exposure data, even when inadequate data require using default values for "n"? How protective is the default relationship, human IDLH = (30-minute LC50, any species)* (0.1)? Are assumptions of 70-kg weight and 10 M3 inhaled air volume appropriate for IDLHs? Is an animal-to-human data uncertainty factor of 1 generally appropriate for IDLHs? Should limited data suggesting genotoxicity or carcinogenicity potential from acute exposures drive an IDLH value? What are the ramifications of basing future IDLHs on toxicity data alone?
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.